Fintel reports that on August 19, 2025, UBS upgraded their outlook for Aveanna Healthcare Holdings (NasdaqGS:AVAH) from Sell to Neutral.

Analyst Price Forecast Suggests 18.62% Downside

As of August 6, 2025, the average one-year price target for Aveanna Healthcare Holdings is $5.93/share. The forecasts range from a low of $5.05 to a high of $7.35. The average price target represents a decrease of 18.62% from its latest reported closing price of $7.28 / share.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for Aveanna Healthcare Holdings is 1,991MM, a decrease of 8.57%. The projected annual non-GAAP EPS is 0.11.

What is the Fund Sentiment?

There are 263 funds or institutions reporting positions in Aveanna Healthcare Holdings. This is an increase of 25 owner(s) or 10.50% in the last quarter. Average portfolio weight of all funds dedicated to AVAH is 0.24%, an increase of 6.72%. Total shares owned by institutions increased in the last three months by 6.37% to 189,334K shares. The put/call ratio of AVAH is 10.06, indicating a bearish outlook.

What are Other Shareholders Doing?

Bain Capital Investors holds 81,601K shares representing 39.06% ownership of the company. No change in the last quarter.

J.H. Whitney Equity Partners VII holds 45,922K shares representing 21.98% ownership of the company. In its prior filing, the firm reported owning 48,521K shares , representing a decrease of 5.66%.

Nut Tree Capital Management holds 12,373K shares representing 5.92% ownership of the company. No change in the last quarter.

Summit Partners L P holds 9,651K shares representing 4.62% ownership of the company.

Littlejohn & Co holds 8,008K shares representing 3.83% ownership of the company. In its prior filing, the firm reported owning 7,562K shares , representing an increase of 5.58%. The firm decreased its portfolio allocation in AVAH by 6.56% over the last quarter.